Anna M. Planas

ORCID: 0000-0002-6147-1880
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Acute Ischemic Stroke Management
  • Neuroscience and Neuropharmacology Research
  • Neurological Disease Mechanisms and Treatments
  • S100 Proteins and Annexins
  • Immune cells in cancer
  • SARS-CoV-2 and COVID-19 Research
  • Immune Response and Inflammation
  • Neurological Disorders and Treatments
  • Biochemical effects in animals
  • Neurogenesis and neuroplasticity mechanisms
  • Heat shock proteins research
  • Atherosclerosis and Cardiovascular Diseases
  • Traumatic Brain Injury and Neurovascular Disturbances
  • COVID-19 Clinical Research Studies
  • Gout, Hyperuricemia, Uric Acid
  • Cell death mechanisms and regulation
  • Mitochondrial Function and Pathology
  • Advanced MRI Techniques and Applications
  • Cytokine Signaling Pathways and Interactions
  • Cerebrovascular and Carotid Artery Diseases
  • Cell Adhesion Molecules Research
  • Stroke Rehabilitation and Recovery
  • Diabetes and associated disorders
  • Advanced Neuroimaging Techniques and Applications

Institut d'Investigacions Biomèdiques de Barcelona
2016-2025

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2016-2025

Consejo Superior de Investigaciones Científicas
2016-2025

Centre for Biomedical Network Research on Rare Diseases
2023-2024

Instituto de Salud Carlos III
2023-2024

Universitat de Barcelona
1996-2023

University of Iowa
2023

Biomedical Research Institute
2007-2023

National Academies of Sciences, Engineering, and Medicine
2023

Clinical Trial Investigators
2022

Paul Bastard Adrian Gervais Tom Le Voyer Jérémie Rosain Quentin Philippot and 95 more Jérémy Manry Eleftherios Michailidis Hans-Heinrich Hoffmann Shohei Eto Marina García-Prat Lucy Bizien Alba Parra-Martínez Rui Yang Liis Haljasmägi Mélanie Migaud Karita Särekannu Julia Maslovskaja Nicolas de Prost Yacine Tandjaoui-Lambiotte Charles‐Édouard Luyt Blanca Amador-Borrero Alexandre Gaudet Julien Poissy Pascal Morel Pascale Richard Fabrice Cognasse Jesús Troya Sophie Trouillet‐Assant Alexandre Bélot Kahina Saker Pierre Garçon Jacques G. Rivière Jean‐Christophe Lagier Stéphanie Gentile Lindsey B. Rosen Elana Shaw Tomohiro Morio Junko Tanaka David Dalmau Pierre‐Louis Tharaux D. Sène Alain Stépanian Bruno Mégarbane Vasiliki Triantafyllia Arnaud Fekkar James R. Heath José Luis Franco Juan‐Manuel Anaya Jordi Solé‐Violán Luisa Imberti Andrea Biondi Paolo Bonfanti Riccardo Castagnoli Ottavia M. Delmonte Yu Zhang Andrew L. Snow Steven M. Holland Catherine M. Biggs Marcela Moncada‐Vélez Andrés A. Arias Lazaro Lorenzo Soraya Boucherit Boubacar Coulibaly Dany Anglicheau Anna M. Planas Filomeen Haerynck Sotiriјa Duvlis Robert L. Nussbaum Tayfun Özçelık Sevgi Keleş Ahmed Aziz Bousfiha Jalila El Bakkouri Carolina Ramírez‐Santana Stéphane Paul Qiang Pan‐Hammarström Lennart Hammarström Annabelle Dupont Alina Kurolap Christine N. Metz Alessandro Aiuti Giorgio Casari Vito Lampasona Fabio Ciceri Lucila Akune Barreiros Elena Domínguez‐Garrido Mateus Vidigal Mayana Zatz Diederik van de Beek Sabina Sahanic Ivan Tancevski Yuriy Stepanovskyy Oksana Boyarchuk Yoko Nukui Miyuki Tsumura Loreto Vidaur Stuart G. Tangye Sonia Burrel Darragh Duffy Lluís Quintana‐Murci Adam Klocperk

Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/mL, in plasma diluted 1 to 10) of IFN-α and/or -ω are found about 10% patients with critical COVID-19 pneumonia, but not subjects asymptomatic infections. We detect auto-Abs 100-fold lower, more physiological, (100 pg/mL, 1/10 dilutions plasma) 13.6% 3,595 COVID-19, including 21% 374 > 80 years, and 6.5% 522 severe COVID-19. These antibodies also detected 18% the 1,124 deceased (aged 20 days-99 years; mean: 70...

10.1126/sciimmunol.abl4340 article EN cc-by Science Immunology 2021-08-10

Two previous pan-European consensus meetings, the 1995 and 2006 Helsingborg were convened to review scientific evidence state of current services identify priorities for research development set targets stroke care decade follow. Adhering same format, European Stroke Organisation (ESO) prepared a Action Plan (ESAP) years 2018 2030, in cooperation with Alliance Europe (SAFE). The ESAP included seven domains: primary prevention, organisation services, management acute stroke, secondary...

10.1177/2396987318808719 article EN cc-by-nc European Stroke Journal 2018-10-29

Abstract There is increasing evidence that astrocytes play important roles in immune regulation the brain. Astrocytes express toll‐like receptors (TLR) and build up responses to innate triggers by releasing proinflammatory molecules. We investigate signaling pathways released molecules after astrocyte TLR4 activation. Purified rodent brain cultures were treated with activator bacterial lipopolysaccharide (LPS). Tools used interfere this system include small interference RNA, inhibitory...

10.1002/glia.21094 article EN Glia 2010-12-01

Numerous treatments have been reported to provide a beneficial outcome in experimental animal stroke models; however, these (with the exception of tissue plasminogen activator) failed clinical trials. To improve translation treatment efficacy from bench bedside, we performed preclinical randomized controlled multicenter trial (pRCT) test potential therapy under circumstances closer design and rigor control trial. Anti-CD49d antibodies, which inhibit migration leukocytes into brain, were...

10.1126/scitranslmed.aaa9853 article EN Science Translational Medicine 2015-08-05

Stroke attracts neutrophils to the injured brain tissue where they can damage integrity of blood-brain barrier and exacerbate lesion. However, mechanisms involved in neutrophil transmigration, location accumulation ischemic are not fully elucidated. Neutrophils reach perivascular spaces vessels after crossing endothelial cell layer basal lamina post-capillary venules, or migrating from leptomeninges following pial vessel extravasation and/or a suggested translocation skull bone marrow. Based...

10.1007/s00401-018-1954-4 article EN cc-by Acta Neuropathologica 2018-12-22
Jérémy Manry Paul Bastard Adrian Gervais Tom Le Voyer Jérémie Rosain and 95 more Quentin Philippot Eleftherios Michailidis Hans-Heinrich Hoffmann Shohei Eto Marina García-Prat Lucy Bizien Alba Parra-Martínez Rui Yang Liis Haljasmägi Mélanie Migaud Karita Särekannu Julia Maslovskaja Nicolas de Prost Yacine Tandjaoui-Lambiotte Charles‐Édouard Luyt Blanca Amador-Borrero Alexandre Gaudet Julien Poissy Pascal Morel Pascale Richard Fabrice Cognasse Jesús Troya Sophie Trouillet‐Assant Alexandre Bélot Kahina Saker Pierre Garçon Jacques G. Rivière Jean‐Christophe Lagier Stéphanie Gentile Lindsey B. Rosen Elana Shaw Tomohiro Morio Junko Tanaka David Dalmau Pierre‐Louis Tharaux D. Sène Alain Stépanian Bruno Mégarbane Vasiliki Triantafyllia Arnaud Fekkar James R. Heath José Luis Franco Juan‐Manuel Anaya Jordi Solé‐Violán Luisa Imberti Andrea Biondi Paolo Bonfanti Riccardo Castagnoli Ottavia M. Delmonte Yu Zhang Andrew L. Snow Steven M. Holland Catherine M. Biggs Marcela Moncada‐Vélez Andrés A. Arias Lazaro Lorenzo Soraya Boucherit Dany Anglicheau Anna M. Planas Filomeen Haerynck Sotiriјa Duvlis Tayfun Özçelık Sevgi Keleş Ahmed Aziz Bousfiha Jalila El Bakkouri Carolina Ramírez‐Santana Stéphane Paul Qiang Pan‐Hammarström Lennart Hammarström Annabelle Dupont Alina Kurolap Christine N. Metz Alessandro Aiuti Giorgio Casari Vito Lampasona Fabio Ciceri Lucila Akune Barreiros Elena Domínguez‐Garrido Mateus Vidigal Mayana Zatz Diederik van de Beek Sabina Sahanic Ivan Tancevski Yuriy Stepanovskyy Oksana Boyarchuk Yoko Nukui Miyuki Tsumura Loreto Vidaur Stuart G. Tangye Sonia Burrel Darragh Duffy Lluís Quintana‐Murci Adam Klocperk Nelli Y. Kann Anna Shcherbina

Significance There is growing evidence that preexisting autoantibodies neutralizing type I interferons (IFNs) are strong determinants of life-threatening COVID-19 pneumonia. It important to estimate their quantitative impact on mortality upon SARS-CoV-2 infection, by age and sex, as both the prevalence these risk death increase with higher in men. Using an unvaccinated sample 1,261 deceased patients 34,159 individuals from general population, we found against IFNs strongly increased...

10.1073/pnas.2200413119 article EN cc-by Proceedings of the National Academy of Sciences 2022-05-16

Abstract Hemorrhagic transformation (HT) is a complication of severe ischemic stroke after revascularization. Patients with low platelet counts do not receive reperfusion therapies due to high risk HT. The immunomodulatory drug fingolimod attenuated HT tissue plasminogen activator in thromboembolic model, but the underlying mechanism unknown. Fingolimod acts on several sphingosine-1-phosphate (S1P) receptors, prevents lymphocyte trafficking inflamed tissues, and affects brain vascular cells....

10.1038/s41598-019-44845-5 article EN cc-by Scientific Reports 2019-06-05
Danyel Lee Jérémie Le Pen Ahmad Yatim Beihua Dong Yann Aquino and 95 more Masato Ogishi Rémi Pescarmona Estelle Talouarn Darawan Rinchai Peng Zhang Magali Perret Zhiyong Liu Iolanda Jordán Şefika Elmas Bozdemir Gülsüm İclal Bayhan Camille Beaufils Lucy Bizien Aurélie Bisiaux Wei‐Te Lei Milena Hasan Jie Chen Christina Gaughan Abhishek Asthana Valentina Libri Joseph M. Luna Fabrice Jaffré Hans-Heinrich Hoffmann Eleftherios Michailidis Marion Moreews Yoann Seeleuthner Kaya Bilgüvar Shrikant Mane Carlos Flores Yu Zhang Andrés A. Arias Rasheed Bailey Agatha Schlüter Baptiste Milisavljevic Benedetta Bigio Tom Le Voyer Marie Materna Adrian Gervais Marcela Moncada‐Vélez Francesca Pala Tomi Lazarov Romain Lévy Anna‐Lena Neehus Jérémie Rosain Jessica N. Peel Yi‐Hao Chan Marie‐Paule Morin Rosa Pino Serkan Belkaya Lazaro Lorenzo Jordi Antón Selket Delafontaine Julie Toubiana Fanny Bajolle Victòria Fumadó Marta L. DeDiego Nadhira Fidouh Flore Rozenberg Jordi Pèrez‐Tur Shuibing Chen Todd Evans Frédéric Geissmann Pierre Lebon Susan R. Weiss Damien Bonnet Xavier Duval Qiang Pan‐Hammarström Anna M. Planas Isabelle Meyts Filomeen Haerynck Aurora Pujol Vanessa Sancho‐Shimizu Clifford L. Dalgard Jacinta Bustamante Anne Puel Stéphanie Boisson‐Dupuis Bertrand Boisson Tom Maniatis Qian Zhang Paul Bastard Luigi D. Notarangelo Vivien Béziat Rebeca Pérez de Diego Carlos Rodríguez‐Gallego Helen C. Su Richard P. Lifton Emmanuelle Jouanguy Aurélie Cobat Laia Alsina Sevgi Keleş Élie Haddad Laurent Abel Alexandre Bélot Lluís Quintana‐Murci Charles M. Rice Robert H. Silverman

Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe condition that follows benign COVID-19. We report autosomal recessive deficiencies of OAS1 , OAS2 or RNASEL five unrelated with MIS-C. The cytosolic double-stranded RNA (dsRNA)–sensing generate 2′-5′-linked oligoadenylates (2-5A) activate the single-stranded RNA–degrading ribonuclease L (RNase L). Monocytic cell lines primary myeloid cells OAS1, OAS2, RNase produce excessive amounts cytokines upon dsRNA acute...

10.1126/science.abo3627 article EN cc-by Science 2022-12-20
Qian Zhang Andrés Pizzorno Lisa Miorin Paul Bastard Adrian Gervais and 95 more Tom Le Voyer Lucy Bizien Jérémy Manry Jérémie Rosain Quentin Philippot Kelian Goavec Blandine Padey Anastasija Čupić Emilie Laurent Kahina Saker Martti Vanker Karita Särekannu Laurent Abel Alessandro Aiuti Saleh Al‐Muhsen Fahd Al‐Mulla Mark S. Anderson Evangelos Andreakos Andrés A. Arias Hagit Baris Feldman Alexandre Belot Catherine M. Biggs Dusan Bogunovic Alexandre Bolze Anastasiia Bondarenko Ahmed Aziz Bousfiha Petter Brodin Yenan T. Bryceson Carlos D. Bustamante Manish J. Butte Giorgio Casari John Christodoulou Antonio Condino-Neto Stefan N. Constantinescu Megan A. Cooper Clifton L. Dalgard Murkesh Desai Beth A. Drolet Jamila El Baghdadi Sara Elva Espinosa‐Padilla Jacques Fellay Carlos Flores Paraskevi C. Fragkou José Luis Barrera Franco Antoine Froidure Ioanna E. Galani Peter K. Gregersen Bodo Grimbacher Filomeen Haerynck David Hagin Rabih Halwani Lennart Hammarström James R. Heath Sarah E. Henrickson Elena W.Y. Hsieh Eystein Husebye Kohsuke Imai Yuval Itan Erich D. Jarvis Timokratis Karamitros Kai Kisand Ourania Koltsida Cheng‐Lung Ku Yu-Lung Lau Yun Ling C. Lucas Tom Maniatis Davood Mansouri László Maródi Isabelle Meyts Joshua D. Milner Kristina Mironska Trine H. Mogensen Tomohiro Morio Lisa F. P. Ng Luigi D. Notarangelo Antonio Novelli Giuseppe Novelli Cliona OʼFarrelly Satoshi Okada Keisuke Okamoto Tayfun Özçelık Qiang Pan‐Hammarström Jean W. Pape Rebeca Pérez de Diego David S. Perlin Graziano Pesole Anna M. Planas Carolina Prando Aurora Pujol Lluis Quintana-Murci Sathishkumar Ramaswamy Vasiliki Rapti Laurent Rénia Igor Resnick

Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19 pneumonia and yellow fever vaccine disease. We report here on 13 patients harboring autoantibodies IFN-α2 alone (five patients) or with IFN-ω (eight from a cohort of 279 (4.7%) aged 6–73 yr influenza pneumonia. Nine four had antibodies high low concentrations, respectively, IFN-α2, six two IFN-ω. The patients’ increased A virus replication in both A549 cells reconstituted human airway epithelia. prevalence...

10.1084/jem.20220514 article EN cc-by The Journal of Experimental Medicine 2022-09-16

Cannabinoids, the active components of marijuana and their derivatives, induce tumor regression in rodents (8). However, mechanism cannabinoid antitumoral action vivo is as yet unknown. Here we show that local administration a nonpsychoactive to mice inhibits angiogenesis malignant gliomas determined by immunohistochemical analyses vascular permeability assays. In vitro experiments at least two mechanisms may be involved this action: direct inhibition endothelial cell migration survival well...

10.1096/fj.02-0795fje article EN The FASEB Journal 2003-01-02

Mechanisms involved in stroke progression are incompletely understood. Ischemic brain injury is characterized by acute local inflammatory response mediated cytokines. Anti-inflammatory cytokines act a feedback loop to inhibit continued proinflammatory cytokine production. We assessed the implication of interleukin (IL)-10 and IL-4 deteriorating ischemic stroke.Two hundred thirty-one patients with within first 24 hours from onset were included. Neurological worsening was defined when Canadian...

10.1161/01.str.0000057976.53301.69 article EN Stroke 2003-03-01

Journal Article A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart Get access Juan-José Fuentes, Fuentes 11Molecular Genetics Department. Cancer Research InstituteHospital Duran i Reynals, Avenida de Castelldefels Km 2 7, L'Hospitalet Llobregat, 08907 Barcelona Search for other works by this author on: Oxford Academic PubMed Google Scholar Melanie A. Pritchard, Pritchard Anna M. Planas, Planas Assumpciò Bosch,...

10.1093/hmg/4.10.1935 article EN Human Molecular Genetics 1995-01-01

Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during first day after focal ischemia and might be involved pathogenesis of tissue damage. We previously showed MMP-9 extracellular space parenchyma along with neutrophil recruitment ischemia. In present study, we tested whether neutrophils were a direct source enhanced ischemic brain. Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates adhesion to endothelial vessel wall, or...

10.1097/01.wcb.0000090680.07515.c8 article EN Journal of Cerebral Blood Flow & Metabolism 2003-12-01
Coming Soon ...